Sean P. Duffy, Chief Executive Officer and Director of Omada Health, Inc. (NASDAQ:OMDA), filed a Form 4 on November 6, 2026, disclosing a stock option exercise and same-day sale of 12,944 shares of common stock on November 4, 2026, executed under a pre-established 10b5-1 trading plan.
Key Highlights
- Option exercise: Duffy exercised a stock option (transaction code M) for 12,944 shares of common stock at an exercise price of $5.82 per share on November 4, 2026.
- Shares sold: All 12,944 acquired shares were sold (transaction code S) at a weighted average price of $19.2159, with individual trades ranging from $19.11 to $19.50, according to the filing.
- Direct ownership after transactions: Following the transactions, Duffy directly held 382,594 shares of common stock.
- Indirect holdings: An additional 851,659 shares are held indirectly in family trusts for the benefit of Duffy's family members; Duffy disclaims beneficial ownership except to the extent of his pecuniary interest.
- 10b5-1 plan: The transactions were made pursuant to a 10b5-1 trading plan adopted by Duffy on March 13, 2026, and "occurred automatically and does not represent a discretionary transaction by the Reporting Person," according to the filing.
- Option fully vested: The filing states that 100% of the shares subject to the exercised option were fully vested and exercisable, with an expiration date of August 21, 2029.
CEO Sean Duffy's November 4 Option Exercise and Share Sale at Omada Health
According to the Form 4 filed with the SEC on November 6, 2026, Sean P. Duffy, who serves as both Chief Executive Officer and Director of Omada Health, Inc., exercised a stock option covering 12,944 shares of common stock at an exercise price of $5.82 per share. On the same date, November 4, 2026, all 12,944 shares acquired through the exercise were disposed of in an open-market sale at a weighted average price of $19.2159 per share. The filing notes the sale was executed across multiple trades at prices ranging from $19.11 to $19.50.
The filing discloses that both the option exercise and the subsequent sale were carried out under a 10b5-1 trading plan that Duffy adopted on March 13, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The filing characterizes the transactions as automatic and states they do not represent discretionary action by Duffy. Following these transactions, Duffy's direct beneficial ownership stood at 382,594 shares of Omada Health common stock.
In addition to his direct holdings, the filing reports 851,659 shares held indirectly through family trusts established for the benefit of Duffy's family members. Duffy disclaims beneficial ownership of those shares except to the extent of his pecuniary interest, as noted in the filing. The stock option exercised had a remaining balance of 103,651 derivative securities following the transaction, all held directly, with an expiration date of August 21, 2029. The Form 4 was signed by Nathan Salha as Attorney-in-Fact for Sean P. Duffy.
What Was Disclosed
Omada Health CEO Sean P. Duffy disclosed the exercise of 12,944 vested stock options at $5.82 per share and the same-day sale of those shares at a weighted average of $19.2159, executed automatically under a 10b5-1 plan adopted March 13, 2026.



Please wait processing your request...